Here, we described a comprehensive study of miRNAs and genes related to EMT in PCa and found that the expression levels of miR-200b, miR-30a, miR-1, TWIST1 and Vimentin could be used in decision-making processes related to primary or adjuvant treatments in the future. This evidence concerns the gene TWIST1 and posterior cortical atrophy.